Clinical observation of CD19-TANK cells in the treatment of relapsed/refractory B-cell lymphoma.
- Author:
Xu Dong ZHANG
1
;
Xiao Rui FU
1
;
Zhen Chang SUN
1
;
Lei ZHANG
1
;
Xin LI
1
;
Ling LI
1
;
Jing Jing WU
1
;
Xin Hua WANG
1
;
Fei Fei NAN
1
;
Yu CHANG
1
;
Hui YU
1
;
Zhao Ming LI
1
;
Ming Zhi ZHANG
1
Author Information
- Publication Type:Journal Article
- MeSH: Antigens, CD19; Humans; Immunotherapy, Adoptive; Lymphoma, B-Cell/therapy*; Receptors, Chimeric Antigen
- From: Chinese Journal of Hematology 2022;43(2):153-156
- CountryChina
- Language:Chinese
